Eris Lifesciences IPO Subscription Status – IPO Subscribed 3.29 times

IPO Watch
Eris Lifesciences IPO Subscription: Detail of Eris Lifesciences IPO Subscription from June 16 to June 20. The things are looking good for the market and Eris Lifesciences will be on demand. The IPO size is big and investors will surely look at the financials which look strong. Eris Lifesciences IPO grey market is active and positive side. This will surely take investors eyes and they will try to subscribe more. Eris Lifesciences gmp will be the key for the IPO but the face value of Rs.1 and the price band might be the hurdle.

Eris Lifesciences IPO Subscription: (Fully Subscribed)

Day QIB NII RII EMP Total
Day 1 0.07 0.02 0.41 0.00 0.12
Day 2 0.82 0.03 1.67 0.33 0.75
Day 3 4.69 0.45 3.51 0.86 3.29

Eris Lifesciences IPO Dates & Price Band:

  • IPO Open: 16-June-2017
  • IPO Close: 20-June-2017
  • IPO Size: Approx Rs. 1740 Crores
  • Face Value: Rs. 1 Per Equity Share
  • Price Band: Rs. 600 to 603 Per Share
  • Listing on: BSE & NSE

Eris Lifesciences IPO Market Lot:

  • Shares: Apply for 24 Shares (Minimum Lot Size)
  • Amount: Rs. 14,472
  • Employee Discount: Rs. 60 Per share 

Eris Lifesciences IPO Allotment & Listing:

  • Basis of Allotment: 23-June
  • Refunds: 27-June
  • Credit to demat accounts: 28-June
  • Listing: 29-June

Table of Contents

Founder of IPOWatch, brings nearly 15 years of experience in IPO analysis and market research. He provides complete coverage of upcoming IPOs, subscription trends, grey market premiums (GMP), and post-listing performance, along with easy-to-understand reviews, insights, and analysis. In his working journey, he has worked with various platforms and received expertise in stock market analysis and primary markets.

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.